SCHWARTZ NORMAN D 4
4 · BIO-RAD LABORATORIES, INC. · Filed Sep 9, 2025
Insider Transaction Report
Form 4
BIO-RAD LABORATORIES, INC.BIO BIO.B
SCHWARTZ NORMAN D
DirectorCEO10% Owner
Transactions
- Exercise/Conversion
Restricted Stock Units
2025-09-06−3,455→ 10,367 totalExercise: $0.00→ Bio-Rad A Common Stock (3,455 underlying) - Exercise/Conversion
Bio-Rad A Common Stock
2025-09-06+3,455→ 444,962 total - Tax Payment
Bio-Rad A Common Stock
2025-09-06$295.43/sh−1,528$451,417→ 443,434 total - Award
Restricted Stock Units
2025-09-05+16,439→ 16,439 totalExercise: $0.00→ Bio-Rad A Common Stock (16,439 underlying)
Holdings
- 361,466
Bio-Rad B Common Stock
- 4,060,054(indirect: By Blue Raven Partners, L.P.)
Bio-Rad B Common Stock
- 13,006(indirect: By Spouse)
Bio-Rad B Common Stock
Footnotes (5)
- [F1]Shares of Class A common stock acquired on the vesting of restricted stock units.
- [F2]The reporting person disclaims beneficial ownership of these shares.
- [F3]The shares are held by a limited partnership of which the reporting person is a limited and general partner. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.
- [F4]Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock.
- [F5]The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant.